Monitoring Patients with Relapsed/Refractory Multiple Myeloma

Opinion
Video

Samer Al'Hadidi, MD, discusses monitoring strategies for patients with relapsed/refractory multiple myeloma who are receiving lenalidomide.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
3 experts in this video
Related Content